Ketorolac vs Chlorpromazine in the Treatment of Acute Migraine Without Aura
Arch Int Med 156:1725-1728, Shrestha,M.,et al, 1996
Drugs for Migraine
The Medical Letter 37:17-20, , 1995
Exacerbation of Idiopathic Parkinson's Disease by Naproxen
BMJ 311:422, Shaunak,S.,et al, 1995
Do Nonsteroidal Anti-Inflammatory Drugs Decrease Risk for Alzheimer's Disease, Rotterdam Study
Neurol 45:1441-1445, Andersen,K.,et al, 1995
Treatment of Paroxysmal Symptoms in Multiple Sclerosis with Ibuprofen
Neurol 44:571-572, Khan,O.A., 1994
Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993
Cancer Pain:Management
Lancet 339:1031-1036, Hanks,G.W.&Justins,D.M., 1992
Episodic Paroxysmal Hemicrania:Two New Cases and A Literature Review
Neurol 42:964-966, Newman,L.C.,et al, 1992
Emergency Treatment of Headache
Neurol 42 (Suppl 2) :43-44992., Rapoport,A.M.&Silberstein,S.D., 1992
Symptomatic and Prophylactic Treatment of Migraine and Tension-Type Headache
Neurol 42:16-21, Schulman,E.A.&Silberstein,S.D., 1992
CNS Side Effects of Nonsteroidal Anti-Inflammatory Drugs, Aseptic Meningitis, Psychosis & Cognitive Dysf
Arch Int Med 151:1309-1313, Hoppmann,R.A.,et al, 1991
Modern Pharmacotherapy of Migraine
Neurologic Clinics, 8:857-8651990., Raskin,N.H., 1990
Herniated Lumbar Intervertebral Disk
Ann Int Med 112:598-603, Deyo,R.A.,et al, 1990
Syncope and Presyncope Associated with Probable Adverse Drug Reactions
Arch Int Med 150:2309-2312, Hanlon,J.T.,et al, 1990
Drug-Induced Meningitis
Neurol 40:163-164, Gordon,M.F.,et al, 1990
Ibuprofen-Induced Meningitis:Detection of Intrathecal IgG Synthesis & Immune Complexes
Neurol 39:1578-1580, Chez,M.,et al, 1989
Treating Migraine, Try Stress Reduction and Simple Analgesia First
BMJ 299:141-142, Clough,C., 1989
Extrapyramidal Reactions to Anti-Inflammatory Drugs
JNNP 51:731-732, Wood,N.,et al, 1988
Efficacy & Safety of Nonsteroidal Anti-Inflammatory Drugs in the Therapy of Diabetic Neuropathy
Arch Int Med 147:1442-1444, Cohen,K.L.&Harris,S., 1987
The Erythrocyte Sedimentation Rate, Guidelines for Rational Use
Ann Int Med 104:515-523, Sox,H.C.,et al, 1986
Acute Exacerbation of Parkinson's Disease with Sulindac
Ann Neurol 17:104-105, Sandyk,R.,et al, 1985
Neglected Conditions Producing Preauricular & Referred Pain
JNNP 46:1067-1072, Friedman,M.H.,et al, 1983
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975
Recurrent Aseptic Meningitis in an Elderly Male, Unusual Prodromal Manifestation of SLE
JAMA 235:1142, Finelli,P.F.,et al, 1975
Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024
Autoimmune Encephalitis Misdiagnosis in Adults
JAMA Neurol 80:30-39, Flanagan,E.P.,et al, 2023
Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome
JAMA Neurol 78:536-547, LaRovere, K.L.,et al, 2021
A 47-Year-Old With Headache, Vertigo, and Double Vision
Neurol 97:e535-e539, Frey, J.,et al, 2021
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
HIV-Associated CD8 Encephalitis: A UK Case Series and Review of Histopathologically Confirmed Cases
Front Neurol 12:628296, Lucas,S.B.,et al, 2021
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Acute Encephalitis in Immunocompetent Adults
Lancet 393:702-716, Venkatesan, A.,et al, 2019
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab
J Immunother Cancer 6:11, Cafuir, L.,et al, 2018
Progressive Multifocal Leukoencephalopathy: Epidemiology, Clinical Manifestations, and Diagnosis
www.UptoDate.com, May, Koralnik, I.J., 2018
Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018
A 77-year-old man presenting with episodic expressive aphasia
Neurol 90:e1822-e1826, Shanklin, A.,et al, 2018
Acute Viral Encephalitis
NEJM 379:357-366, Tyler,K.L., 2018
Clnicopathologic Conference Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis
NEJM 379:870-878, CASE 27-2018, 2018
Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018
Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018
Clinical Pathologic Conference, West Nile Virus Encephalitis
NEJM 377:1878-1886, Case 34-2017, 2017
Paraneoplastic and Autoimmune Encephalitis
UptoDate July, Dalmau, J.,et al, 2017
Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017
Neurological Autoantibody Prevalence in Epilepsy on Unknown Etiology
JAMA Neurol 74:397-402,384, Dubey, D.,et al, 2017
Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis
AJNR 38:1070-1078, Kelley, B.P.,et al, 2017
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016